EVALUATION OF BOTULINUM NEUROTOXIN-A IN THE TREATMENT OF MASSETER MUSCLE HYPERTROPHY AMONG A SAMPLE OF IRAQI PATIENTS
| dc.contributor.author | Ghufran Majid Hayder | |
| dc.contributor.author | Mohammed Ahmed Rasheed | |
| dc.contributor.author | Mohammed Abbood Al-Maliky | |
| dc.date.accessioned | 2025-12-31T15:37:41Z | |
| dc.date.issued | 2023-06-30 | |
| dc.description.abstract | Masseteric muscle hypertrophy is considered a benign disease that is characterized by the enlargement of the masseter muscles. Botulinum neurotoxin-A is considered one of the most poisonous biological materials known | |
| dc.format | application/pdf | |
| dc.identifier.uri | https://scholarexpress.net/index.php/wbph/article/view/2982 | |
| dc.identifier.uri | https://asianeducationindex.com/handle/123456789/49434 | |
| dc.language.iso | eng | |
| dc.publisher | Scholar Express Journals | |
| dc.relation | https://scholarexpress.net/index.php/wbph/article/view/2982/2560 | |
| dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
| dc.source | World Bulletin of Public Health; Vol. 23 (2023): WBPH; 209-215 | |
| dc.source | 2749-3644 | |
| dc.subject | Botulinum neurotoxin | |
| dc.subject | masseter muscle | |
| dc.subject | hypertrophy | |
| dc.title | EVALUATION OF BOTULINUM NEUROTOXIN-A IN THE TREATMENT OF MASSETER MUSCLE HYPERTROPHY AMONG A SAMPLE OF IRAQI PATIENTS | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.type | Peer-reviewed Article |
item.page.files
item.page.filesection.original.bundle
pagination.showing.detail
loading.default
- item.page.filesection.name
- hayder_2023_evaluation_of_botulinum_neurotoxin-a_in.pdf
- item.page.filesection.size
- 263.92 KB
- item.page.filesection.format
- Adobe Portable Document Format